Table of Contents

CVM News & Meetings

The Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) Office of New Animal Drug Evaluation/Division of Therapeutic Drugs for Food Animals is planning a scientific workshop on Swine Mycoplasmal Pneumonia to be held March 6-7, 2002, at the Doubletree Hotel Kansas City, 1301 Wyandotte St., Kansas City, MO, 64105, (816) 474-6664.  The workshop immediately follows the Annual American Association of Swine Veterinarians (AASV) Meeting (March 2-5, 2002), in Kansas City, Missouri. This workshop is a Public Meeting. The topic to be discussed is how to evaluate drug effectiveness against swine Mycoplasmal respiratory disease.

• Swine Mycoplasmal Workshop transcription text

  • Day 1 Tape 1: Naba Das, Lisa Tokach, Brad Thacker, Monte McCaw

  • Day 1 Tape 2: Monte McCaw, Eric Bush, Kent Schwartz

  • Day 1 Tape 3: Chris Minion, Eileen Thacker, John Kolb

  • Day 1 Tape 4: Kolb, Pijoan

  • Day 1: Finish of Discussion following Dr. Pijoan's talk, page 1; Day 2: Korlund, Hollis, pages 2-30

  • Day 2 Tape 2: Bradford, Thacker, Pijoan, Burnsteel

  • Day 2 Tape 3: Burnsteel, Derr; Breakout Session Discussion

  • Day 2 Tape 4: Breakout Sesson Discussion

• Swine Mycoplasmal Workshop speaker abstracts and presentations

  • FDA/CVM/ONADE/Swine Mycoplasma Pneumonia Workshop

  • Mycoplasma hyopneumoniae Associated Respiratory Disease on the Farm

  • Substantial Evidence of Drug Effectiveness

  • Genomic Sequencing of Mycoplasma hyopneumoniae, Virulence Factors, and Vaccines

  • Mycoplasma Diagnostics

  • The epidemiology of Mycoplasma hyopneumoniae

  • Interactions Between M. hyopneumoniae and Other Pathogens

  • Measurement of Intervention Strategies for the Treatment and (Prevention?) of Mycoplasmal Pneumonia using a Model System

  • "Clinical Trials and Clinical Endpoints"

  • Swine Respiratory Disease:Statistical Considerations

  • Mycoplasmal pneumonia in Swine Immunologic Considerations

  • View from the Farm-Mycoplasmal pneumonia

  • Pathological Diagnosis of Mycoplasmosis in Swine

  • Current Trends in Presentation of Disease Associated with M. hyopneumoniae

• The Reason for the Workshop

• The Relevance of Swine Mycoplasmal Pneumonia to Food Safety: Prudent Antimicrobial Use

• Backgrounder on Swine Mycoplasmal Pneumonia

• Letter of Invitation

• Registration Form

• Comment on the FR notice or workshop

• Federal Register (FR) Notice: Workshop Announcement

• Draft Agenda

• Hotel Information

The Reason for the Workshop

The Division of Therapeutic Drugs for Food Animals needs to obtain scientific input from a broad public forum to determine an acceptable method for evaluating drug effectiveness against swine Mycoplasmal respiratory disease.  Mycoplasma hyopneumoniae is a major pathogen in “Porcine Respiratory Disease Complex” (PRDC).  PRDC is a significant problem in the swine industry in the US, and worldwide.  This workshop will provide a necessary forum for leveraging scientific resources, including top experts in swine Mycoplasmal pneumonia.  The workshop is part of CVM’s leveraging initiative aimed at increasing interaction with industry, academia, practitioners and other government agencies. 

The Relevance of Swine Mycoplasmal Pneumonia to Food Safety: Prudent Antimicrobial Use

The best approach for treating M. hyopneumoniae is not yet known.  Veterinarians and swine producers lack scientifically supportable label directions for new animal drugs to treat Mycoplasmal pneumonia.  Veterinarians and swine producers are best equipped to protect the public health through prudent drug use practices when new animal drugs are approved and labeled to treat important disease conditions such as Mycoplasmal pneumonia.  FDA’s Center for Veterinary Medicine enables the availability of approved new animal drugs by clearly defining appropriate study design and data requirements.  This workshop will help protect the public health by accelerating the availability of approved, properly labeled new animal drugs. 

You may register for the workshop through FDA electronic dockets .  The workshop docket number is 02N-0027.  If you have any questions about registration, please contact Mrs. Irma Carpenter (CVM) at 301-827-7580.

Federal Register (FR) Notice: Workshop Announcement

Note: The Federal Register Notice (Document No. CV01112) may be accessed from the FDA homepage.  The Workshop FDA Electronic Docket number is 02N-0027.

CVM A-Z Index | Contact CVM | About CVM | Site Map
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page